Imunon, Inc.
IMNNNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $5.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.96$5.29
- Volume (live)
- -
- Avg. volume (3M)
- 136.89K
Imunon (IMNN) Stock Price & Financial Analysis
Imunon Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.01 - $1.05 |
|---|---|
| 52-Week High | $5.29 |
| 52-Week Low | $0.96 |
| Open | $1.05 |
| Volume (last close) | 55.42K |
| Average Volume (3M) | 136.89K |
| 50-Day MA | $1.45 |
|---|---|
| 200-Day MA | $2.40 |
| 1-Year Change | −79.17% |
| Market Cap | 5.55M |
|---|---|
| Shares Outstanding | 5.23M |
| Price to Book (P/B) | 1.32 |
| EV/EBITDA | -0.44 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Imunon at a Glance
As of the Oct 16, 2026 close, Imunon (IMNN) has a market capitalization of $5.55M.
As of its latest reported balance sheet, it holds $6.86M in cash and securities against $7.85M of debt, a net debt position of $980.91K.
Imunon does not currently pay a dividend.
The share price is down 79.2% over the past year. At $1.02 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.96 to $5.29, below its 200-day moving average of $2.40.
Frequently Asked Questions About Imunon
What is the current stock price for IMNN?
As of the Oct 16, 2026 close, IMNN stock trades at $1.02. The 52-week range is $0.96–$5.29, with a day range of $1.01–$1.05.
What is the P/E ratio for IMNN?
The P/E ratio (Price-to-Earnings) for IMNN is shown in the Key Statistics section. This valuation metric helps compare Imunon, Inc. to industry peers.
Does IMNN pay dividends?
Imunon does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMNN?
Analyst ratings and recommendations for IMNN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IMNN?
As of the Oct 16, 2026 close, Imunon's market capitalization is $5.3M, classifying it as a micro-cap company. Imunon operates in the Healthcare sector within the Biotechnology industry.